Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06253871
Title A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Iambic Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90089 United States Details
Comprehensive Hematology Oncology RECRUITING Saint Petersburg Florida 33709 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
START - Midwest Cancer Research Center RECRUITING Grand Rapids Michigan 49546 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
OU Health Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology - Austin RECRUITING Austin Texas 78758 United States Details
NEXT Oncology - Dallas RECRUITING Dallas Texas 75039 United States Details
Mary Crowley Cancer Research RECRUITING Dallas Texas 75230 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT Oncology - Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field